Tectonic Therapeutic (TECX) Accumulated Expenses (2017 - 2026)

Tectonic Therapeutic (TECX) has 10 years of Accumulated Expenses data on file, last reported at $9.0 million in Q1 2026.

• On a quarterly basis, Accumulated Expenses rose 82.86% year-over-year to $9.0 million in Q1 2026; TTM through Mar 2026 was $9.0 million, a 82.86% increase from a year earlier, with the FY2025 full-year figure at $7.3 million, down 6.5% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $9.0 million, up from $7.3 million in the prior quarter.
• Over the last five years, Accumulated Expenses for TECX reached as high as $20.0 million in Q2 2024 and fell as low as $2.4 million in Q3 2023.
• Historically, Accumulated Expenses has averaged $8.2 million across 5 years, with a median of $7.3 million in 2025.
• On a YoY basis, Accumulated Expenses climbed as much as 441.81% in 2024 and fell as far as 72.25% in 2024.
• Year by year, Accumulated Expenses stood at $11.7 million in 2022, then tumbled by 30.61% to $8.1 million in 2023, then decreased by 3.57% to $7.8 million in 2024, then decreased by 6.5% to $7.3 million in 2025, then gained by 22.25% to $9.0 million in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $9.0 million in Q1 2026, $7.3 million in Q4 2025, and $6.8 million in Q3 2025.